• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非亲缘供者干细胞移植后迟发性非感染性肺部并发症的发病率、结局及危险因素

Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation.

作者信息

Patriarca F, Skert C, Sperotto A, Damiani D, Cerno M, Geromin A, Zaja F, Stocchi R, Prosdocimo S, Fili' C, Fanin R

机构信息

Division of Haematology, Bone Marrow Transplantation Unit, Department of Clinical and Morphological Research, University Hospital, Udine, Italy.

出版信息

Bone Marrow Transplant. 2004 Apr;33(7):751-8. doi: 10.1038/sj.bmt.1704426.

DOI:10.1038/sj.bmt.1704426
PMID:14755316
Abstract

We evaluated the incidence, the risk factors, and the outcome of late-onset noninfectious pulmonary complications (LONIPCs) among 50 patients who underwent allogeneic stem cell transplantation from unrelated donors. Of the 39 patients surviving at least 3 months, 10 (26%) fulfilled the diagnostic criteria of LONIPCs and were further subclassified as having bronchiolitis obliterans (four patients), bronchiolitis obliterans with organizing pneumonia (four patients), and interstitial pneumonia (two patients). Two patients had a durable partial remission after treatment with prednisone and cyclosporine; the remaining eight patients did not respond to treatment and five of them died of respiratory failure. Advanced stage of disease at transplant and chronic extensive graft-versus-host disease (GVHD) were significantly associated with the development of LONIPCs. Pulmonary function test (PFT) results before transplantation were similar in all patients, but patients with LONIPCs had a significant decrease in PFT indexes at the third month after BMT compared with controls. Moreover, the rate of cyclosporine taper during the fourth and fifth months after BMT was significantly more rapid in patients with LONIPCs than in controls, suggesting that the risk of LONIPCs may be influenced by a faster reduction of GVHD prophylaxis.

摘要

我们评估了50例接受非血缘供者异基因干细胞移植患者的迟发性非感染性肺部并发症(LONIPC)的发生率、危险因素及预后。在至少存活3个月的39例患者中,10例(26%)符合LONIPC的诊断标准,并进一步分为闭塞性细支气管炎(4例)、闭塞性细支气管炎伴机化性肺炎(4例)和间质性肺炎(2例)。2例患者经泼尼松和环孢素治疗后获得持久部分缓解;其余8例患者治疗无效,其中5例死于呼吸衰竭。移植时疾病分期较晚和慢性广泛性移植物抗宿主病(GVHD)与LONIPC的发生显著相关。所有患者移植前的肺功能测试(PFT)结果相似,但与对照组相比,LONIPC患者在骨髓移植后第3个月时PFT指标显著下降。此外,LONIPC患者在骨髓移植后第4和第5个月环孢素减量的速度明显快于对照组,提示LONIPC的风险可能受GVHD预防措施更快减量的影响。

相似文献

1
Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation.非亲缘供者干细胞移植后迟发性非感染性肺部并发症的发病率、结局及危险因素
Bone Marrow Transplant. 2004 Apr;33(7):751-8. doi: 10.1038/sj.bmt.1704426.
2
Late-onset non-infectious pulmonary complications following allogeneic hematopoietic stem cell transplantation in children.儿童异基因造血干细胞移植后迟发性非感染性肺部并发症
Bone Marrow Transplant. 2009 Sep;44(5):303-8. doi: 10.1038/bmt.2009.33. Epub 2009 Apr 6.
3
Graft versus host-associated pulmonary disease and other idiopathic pulmonary complications after hematopoietic stem cell transplant.造血干细胞移植后移植物抗宿主相关的肺部疾病及其他特发性肺部并发症
Semin Respir Crit Care Med. 2005 Oct;26(5):482-9. doi: 10.1055/s-2005-922031.
4
Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation.闭塞性细支气管炎综合征(BOS)、机化性肺炎型闭塞性细支气管炎(BOOP)以及异基因造血干细胞移植后其他迟发性非感染性肺部并发症。
Biol Blood Marrow Transplant. 2007 Jul;13(7):749-59. doi: 10.1016/j.bbmt.2007.05.001.
5
[Clinical study on pulmonary complications after allogeneic peripheral blood stem cell transplantation].[异基因外周血干细胞移植术后肺部并发症的临床研究]
Zhonghua Xue Ye Xue Za Zhi. 2006 Jun;27(6):366-9.
6
Late-onset noninfectious pulmonary complications in adult allogeneic hematopoietic cell transplant recipients.成人异基因造血细胞移植受者的迟发性非感染性肺部并发症。
Transplantation. 2011 Apr 15;91(7):798-803. doi: 10.1097/TP.0b013e31820c85fa.
7
Outcome and treatment of late-onset noninfectious pulmonary complications after allogeneic haematopoietic SCT.异基因造血干细胞移植后迟发性非感染性肺部并发症的结果和治疗。
Bone Marrow Transplant. 2010 Dec;45(12):1719-27. doi: 10.1038/bmt.2010.48. Epub 2010 Mar 8.
8
Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation.造血干细胞移植中的闭塞性细支气管炎及其他迟发性非感染性肺部并发症
Bone Marrow Transplant. 2001 Sep;28(5):425-34. doi: 10.1038/sj.bmt.1703142.
9
Lung function, pulmonary complications, and mortality after allogeneic blood and marrow transplantation in children.儿童异基因造血干细胞移植后的肺功能、肺部并发症及死亡率
Biol Blood Marrow Transplant. 2009 Jul;15(7):817-26. doi: 10.1016/j.bbmt.2009.03.019.
10
Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantation.干细胞移植后迟发性非感染性肺部并发症的发生对生存的影响。
Haematologica. 2006 Sep;91(9):1268-72.

引用本文的文献

1
Non-infectious pulmonary complications after haematopoietic progenitor transplantation: a diagnostic approach.造血祖细胞移植后的非感染性肺部并发症:一种诊断方法
J Thorac Dis. 2024 Dec 31;16(12):8771-8781. doi: 10.21037/jtd-24-1063. Epub 2024 Dec 20.
2
Pulmonary complications of bone marrow transplantation.骨髓移植的肺部并发症。
Breathe (Sheff). 2024 Oct 1;20(3):240043. doi: 10.1183/20734735.0043-2024. eCollection 2024 Oct.
3
Evaluation of risk for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens.
采用清髓性预处理方案进行异基因造血细胞移植后闭塞性细支气管炎综合征风险的评估。
Bone Marrow Transplant. 2024 Dec;59(12):1744-1753. doi: 10.1038/s41409-024-02422-z. Epub 2024 Sep 27.
4
How I diagnose and treat organizing pneumonia in hematopoietic cell transplant recipients.如何诊断和治疗造血细胞移植受者的机化性肺炎
Blood. 2024 Sep 5;144(10):1048-1060. doi: 10.1182/blood.2023023249.
5
Systematic Review of Systemic Corticosteroids for Treatment of Organizing Pneumonia.系统性皮质类固醇治疗机化性肺炎的系统评价
Open Respir Arch. 2022 Sep 19;4(4):100211. doi: 10.1016/j.opresp.2022.100211. eCollection 2022 Oct-Dec.
6
Clinical characteristics of late-onset interstitial pneumonia after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后迟发性间质性肺炎的临床特征。
Int J Hematol. 2023 Aug;118(2):242-251. doi: 10.1007/s12185-023-03624-9. Epub 2023 Jun 9.
7
Selection bias in follow-up studies of stem cell transplantation survivors: an experience within the Maastricht Observational study of late effects after Stem cell trAnsplantation (MOSA).随访研究中的选择偏倚:来自 Maastricht 干细胞移植后晚期效应观察研究(MOSA)的经验。
Ann Hematol. 2023 Mar;102(3):641-649. doi: 10.1007/s00277-022-05070-9. Epub 2022 Dec 31.
8
Longitudinal Survival Outcomes in Allogeneic Stem Cell Transplantation: An Institutional Experience.异基因干细胞移植的纵向生存结果:一项机构经验
Cancers (Basel). 2022 Nov 14;14(22):5587. doi: 10.3390/cancers14225587.
9
Long-Term Health Effects of Curative Therapies on Heart, Lungs, and Kidneys for Individuals with Sickle Cell Disease Compared to Those with Hematologic Malignancies.与血液系统恶性肿瘤患者相比,镰状细胞病患者的心脏、肺和肾脏的治愈性疗法的长期健康影响。
J Clin Med. 2022 May 31;11(11):3118. doi: 10.3390/jcm11113118.
10
Fibrotic Cystic Lung Disease Post Hematopoietic Stem Cell Transplant: Who is the Culprit?造血干细胞移植后纤维化囊性肺病:罪魁祸首是谁?
Clin Med Insights Case Rep. 2022 May 13;15:11795476221097317. doi: 10.1177/11795476221097317. eCollection 2022.